MOTS-c is unusual among signalling peptides because of where it is encoded. Most peptides are products of the nuclear genome; MOTS-c is encoded in mitochondrial DNA, which is what makes it scientifically interesting.
Mitochondria are usually described as the cell's energy producers. They also carry their own small genome, separate from the DNA in the nucleus — a legacy of their evolutionary origin.
MOTS-c is encoded within that mitochondrial genome, specifically in the 12S rRNA region. Its name stands for mitochondrial open reading frame of the twelve S rRNA type-c.
The broader idea this supports is that mitochondria are not only producing energy but encoding peptides that signal outward about their state. MOTS-c is among the most studied examples of that concept, which is why it attracts attention beyond its own specific effects.
MOTS-c was characterised in work published in Cell Metabolism in 2015, which identified it as a mitochondrial-derived peptide with metabolic signalling activity.
That paper remains the standard reference point, and the literature since has largely developed and tested the ideas it set out.
Three areas recur in the research literature.
This distinction matters and is frequently blurred.
There are human studies examining circulating MOTS-c levels and their association with metabolic measures, exercise, and age. These are observational: they measure what is already present in people and look for correlations.
That is a different kind of evidence from an interventional trial, where a compound is administered and outcomes measured. No interventional trial has established that administering MOTS-c produces any effect in humans.
An association between naturally occurring levels of something and a health measure does not establish that supplying more of it changes anything. This is one of the most common inferential errors in peptide discussion.
MOTS-c holds no marketing authorisation as a medicine in the United Kingdom or elsewhere, and no clinical trial has established efficacy for any indication.
It is supplied for laboratory research use only.
This article is reference material describing published research. It is not medical advice, not a therapeutic claim, and contains no dosing or administration guidance.